HYPERFINE, INC.


Associated tags: FDA, Jonathan Rothberg, Magnetic resonance imaging, Swoop, National Medal, DNA, Patient, Operating, MRI, Therapy, Intensive care medicine, Butterfly network, Hyperfine structure, Medical imaging, Health, Medical Devices, Research

Locations: UNITED STATES, NORTH AMERICA, CONNECTICUT

Hyperfine to Present at the 42nd Annual Cowen Healthcare Conference

Retrieved on: 
Tuesday, March 1, 2022
Diagnosis, Patient, Magnetic resonance imaging, Hyperfine structure, Swoop, Income, Paola Lattus, FDA, Conference, Interest, MRI, GLOBE, High-dependency unit, Medical imaging

GUILFORD, Conn., March 01, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced that the company will be participating in the upcoming 42nd AnnualCowen Healthcare Conference.

Key Points: 
  • GUILFORD, Conn., March 01, 2022 (GLOBE NEWSWIRE) -- Hyperfine, Inc. (Nasdaq: HYPR), the creator of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced that the company will be participating in the upcoming 42nd AnnualCowen Healthcare Conference.
  • Hyperfine management is scheduled to present onWednesday, March 9th, 2022,at2:10 PM Eastern Time.
  • Interested parties may access a live and archived webcast of the presentation on the Investors section of the companys website at: https://investors.hyperfine.io .
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.

Queen’s University Radiology Receives Hyperfine Portable MRI to Improve Access to Care for Canadian Patients in Remote Northern Communities

Retrieved on: 
Wednesday, February 16, 2022
Magnetic resonance imaging, Income, ERS, Weeneebayko Area Health Authority, Patient, ADC, Map, Picture archiving and communication system, PACS, DWI, Risk, MOOSE, ORS, Licensed practical nurse, Management, Weather, MRI, U.S. Securities and Exchange Commission, Transport, Security (finance), Private Securities Litigation Reform Act, Nasdaq, Health, Health Canada, Intensive care unit, Paola Lattus, Communications system, Technology, FDA, Deep learning, Queen's University, Partnership, Marketing, High-dependency unit, Growth, POC, Diagnosis, FLAIR, COVID-19, University, Medical imaging, GLOBE, Swoop, Hyperfine structure

Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON.

Key Points: 
  • Until now, patients needing routine or emergent care required transportation by medical charter flight hundreds of miles away to either Timmins or Kingston, ON.
  • Queens University intends to utilize Swoop as part of a study to build evidence regarding the utility and affordability of a portable point of care (POC) MRI in a remote setting.
  • Queens University is situated on traditional Anishinaabe and Haudenosaunee territory and provides medical services to a predominantly Indigenous population in the Weeneebayko Area Health Authority (WAHA) in Northern Ontario.
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.

Hyperfine Appoints Chip Truwit, M.D. as Senior Medical Director

Retrieved on: 
Tuesday, February 8, 2022
Private Securities Litigation Reform Act, GLOBE, Humanitarian use licenses, Growth, Radiology, U.S. Securities and Exchange Commission, Income, Google Images, University, Medtronic, Marketing, Magnetic resonance imaging, Hennepin County Medical Center, FDA, Hospital, Neuroscience, Patient, Technology, Security (finance), Diagnosis, Paola Lattus, Swoop, Nasdaq, Philips, Book, Partnership, MRI, Public sector, High-dependency unit, COVID-19, Medical imaging, Hyperfine structure

GUILFORD, Conn., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hyperfine Inc. (Nasdaq:HYPR), creator of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced the appointment of Dr. Chip Truwit as senior medical director.

Key Points: 
  • GUILFORD, Conn., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Hyperfine Inc. (Nasdaq:HYPR), creator of Swoop, the first FDA-cleared portable magnetic resonance imaging (MRI) system, today announced the appointment of Dr. Chip Truwit as senior medical director.
  • We feel privileged to welcome Dr. Truwit to the Hyperfine team, Khan Siddiqui, M.D., Hyperfine's chief medical officer and chief strategy officer, said.
  • Before joining Hyperfine, Truwit served as chief medical officer of diagnostic imaging and medical officer of precision diagnosis at Philips Healthcare, where he provided medical leadership and radiology expertise.
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.

M Health Fairview University of Minnesota Medical Center Receives First Hyperfine Portable MRI to Grow its Advanced Imaging Systems Offering

Retrieved on: 
Wednesday, January 19, 2022

Swoops portable design and easy-to-use interface make it accessible for use in hospitals, clinics, and other settings outside of the conventional MRI suite.

Key Points: 
  • Swoops portable design and easy-to-use interface make it accessible for use in hospitals, clinics, and other settings outside of the conventional MRI suite.
  • The Swoop system is also a fraction of the cost of a traditional MRI unit, which helps hospitals and patients save valuable time and financial resources.
  • To date, the Hyperfine Swoop Portable MRI System has been deployed at Yale New Haven Hospital, University of California Irvine Medical Center, Ohio State University Wexner Medical Center, and the University of Illinois at Chicagos Surgical Innovation Training Lab.
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.

Hyperfine Reports Preliminary Unaudited 2021 Revenue and Swoop® System Installations

Retrieved on: 
Monday, January 10, 2022
Depreciation, Traction, High-dependency unit, Growth, MRI, Security (finance), Magnetic resonance imaging, Humanitarian use licenses, Patient, Income, Hospital, Bill & Melinda Gates Foundation, Marketing, Sale, U.S. Securities and Exchange Commission, GAAP, Partnership, Review, Time, Research, R, Paola Lattus, Private Securities Litigation Reform Act, Software, Nasdaq, Technology, Mission statement, RTA, COVID-19, FDA, Bill, BMGF, Medical imaging, Risk management, Hyperfine structure, Swoop

Hyperfines revenue for the years ended December 31, 2021, and 2020 is derived from commercial sales and RTA sales.

Key Points: 
  • Hyperfines revenue for the years ended December 31, 2021, and 2020 is derived from commercial sales and RTA sales.
  • Grant fulfillment installations consist of shipments of Swoop units to hospitals and other clinical facilities designated by the Bill & Melinda Gates Foundation (BMGF).
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the worlds first FDA-cleared portable MRI system.
  • In certain cases, Hyperfine has provided expected ranges, rather than specific amounts, because these results are preliminary and subject to change.

Hyperfine Announces Formation Of Medical Advisory Board

Retrieved on: 
Thursday, October 14, 2021

The Hyperfine MAB is composed of world-renowned doctors specializing in neurology, radiology, neurosurgery, and global health.

Key Points: 
  • The Hyperfine MAB is composed of world-renowned doctors specializing in neurology, radiology, neurosurgery, and global health.
  • Members of the Hyperfine MAB include:
    Michael Brant-Zawadzki, M.D., Senior Physician Executive at Hoag Health Network in Newport Beach, California.
  • "I look forward to working with my fellow Medical Advisory Board members to expand the clinical potential for Hyperfine's technology."
  • Hyperfine, Inc. is the groundbreaking medical device company that created Swoop, the world's first FDA-cleared portable MRI system.